“…The attempts to restore/influence gamma power in AD are still at an investigational stage, as no changes in AD biomarkers in humans after such treatment have been reported to date (Manippa et al, 2022). However, gamma‐patterned AD treatment has a clear clinical potential because a steady state gamma induced in sensory cortex can propagate into deeper brain areas in rodents (Adaikkan et al, 2019; Li et al, 2021; Martorell et al, 2019; Soula et al, 2023) and humans (Jones et al, 2019). Given the importance of corticosteroids in mediating circadian rhythms (Oster et al, 2017), our data on beneficial effects of 40 Hz sensory stimulation in corticosterone‐injected APP transgenic rats (Figure 2), which are in accord with findings that similar sensory stimulation improves the circadian clock in APP/PS1 mice (Yao et al, 2020) and sleep in AD patients (Cimenser et al, 2021), support this approach.…”